Skip to main content

Evonik in TAA exit

Evonik has sold its TAA derivatives business to Italian chemical company Sabo, which claims to be one of the world's leading manufacturers of light stabilisers. Terms are not being disclosed and the sale is expected to close in early 2023. The sale is part of Evonik’s continuing strategy of focusing its portfolio on speciality chemicals and divesting businesses that no longer fit.

Green steam for Sasol site

Hamburger Energiewerke, Hamburg’s municipal utility, is to build a biomass cogeneration facility at Sasol Chemicals’ Brunsbüttel site. When fully operational in 2025, this will supply at least 70,000 MW/year of ‘green steam’ to the site, enabling Sasol Chemicals to reduce CO2 emissions by some 13,000 tonnes/year. The company is targeting a 30% reduction in Scope 1 and 2 greenhouse gas emissions by 2030.

Evonik reducing natural gas dependency

Evonik has made several moves to limit its dependence on Russian supplies of natural gas at its German sites. The company said that this is less of an issue in other countries but “in Germany, on the other hand, a loss of Russian gas supplies would seriously jeopardise chemical production”.

Otto Roelen Medal for Robert Franke

Dechema and the German Catalysis Society have awarded the 2022 Otto Roelen Medal to Professor Robert Franke for his work on developing catalytic carbonylation, particularly hydroformylation, from theory to industrial implementation. The award will be made at the society’s AGM in Weimar on 18 June.

Franke is adjunct professor at Ruhr University Bochum and also heads up hydroformylation research at the Evonik Performance Materials site in Marl. His research focuses on homogeneous catalysis, process intensification and the modelling of catalytic processes.

Evonik acquires Porocel Group

Evonik has acquired the Porocel Group, which has developed a technology for the rejuvenation of desulfurisation catalysts in a $210 million deal. This deal is scheduled to close by the end of 2020, subject to regulatory approval.

Executive board chairman Christian Kullmann commented: “This acquisition is the next logical step in the strategic development of our portfolio. Our focus is on stable and high-margin speciality chemicals.”

Subscribe to Marl